Expertise in
2
conditions

Uwe Trefzer

Berlin, BE, DE 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
2
conditions
Berlin, BE, DE 

Overview

Uwe Trefzer practices practicing medicine in Berlin, Germany.

Mr. Trefzer is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Basal Cell Skin Cancer, Melanoma, and Metastatic Brain Tumor.

He is actively involved in clinical research, co-authoring 32 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Berlin, BE, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase III Study Comparing the Efficacy of the Combination of Doxorubicin and the Tumor-targeting Human Antibody-cytokine Fusion Protein L19TNF to Doxorubicin Alone as First-line Therapy in Patients With Advanced or Metastatic Soft Tissue Sarcoma
A Phase III Study Comparing the Efficacy of the Combination of Doxorubicin and the Tumor-targeting Human Antibody-cytokine Fusion Protein L19TNF to Doxorubicin Alone as First-line Therapy in Patients With Advanced or Metastatic Soft Tissue Sarcoma
Enrollment Status: Recruiting
Publish Date: April 08, 2024
Intervention Type: Drug
Study Drugs: Onfekafusp Alpha, Doxorubicin
Study Phase: Phase 3
Phase II Study of the Tumor-targeting Human F16IL2 Monoclonal Antibody-cytokine Fusion Protein in Combination With Paclitaxel in Patients With Metastatic Merkel Cell Carcinoma
Phase II Study of the Tumor-targeting Human F16IL2 Monoclonal Antibody-cytokine Fusion Protein in Combination With Paclitaxel in Patients With Metastatic Merkel Cell Carcinoma
Enrollment Status: Terminated
Publish Date: May 18, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

32 Total Publications

Long-term efficacy and safety of sonidegib in patients with advanced basal cell carcinoma: 42-month analysis of the phase II randomized, double-blind BOLT study.
Long-term efficacy and safety of sonidegib in patients with advanced basal cell carcinoma: 42-month analysis of the phase II randomized, double-blind BOLT study.
Journal: The British journal of dermatology
Published: September 18, 2019

Frequently Asked Questions about Uwe Trefzer

Is Uwe Trefzer a top-rated expert for Basal Cell Skin Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Uwe Trefzer is classified as an Advanced expert for Basal Cell Skin Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Uwe Trefzer participate in research or clinical trials?

Yes. Uwe Trefzer has published 32 articles and abstracts on conditions like Basal Cell Skin Cancer. You can view a list of Uwe Trefzer's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Trefzer's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile